Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
▼Teriflunomide for multiple sclerosis.
Attributions and self-efficacy for physical activity in multiple sclerosis.
Diaphragm Breathing Movement Measurement using Ultrasound and Radiographic Imaging: A Concurrent Validity.
Post-acute serum eosinophil and neutrophil-associated cytokine/chemokine profile can distinguish between patients with neuromyelitis optica and multiple sclerosis; and identifies potential pathophysiological mechanisms - A pilot study.
Teriflunomide: A Once-Daily Oral Medication for the Treatment of Relapsing Forms of Multiple Sclerosis.
Neuromyelitis Optica (NMO) with Abdominal Tuberculosis (TB).
Perception of muscular effort during dynamic elbow extension in multiple sclerosis.
Statistical image analysis of longitudinal RAVENS images.
Microglia regulate hippocampal neurogenesis during chronic neurodegeneration.
The signal intensity ratio of the optic nerve to ipsilateral frontal white matter is of value in the diagnosis of acute optic neuritis.
An unusual presentation of X-linked adrenoleukodystrophy.
Comment on the Paper by Esen et al. Entitled ´Evaluation of Choroidal Vascular Changes in Patients with Multiple Sclerosis Using Enhanced Depth Imaging Optical Coherence Tomography´.
Reliability and responsiveness of cardiopulmonary exercise testing in fatigued persons with multiple sclerosis and low to mild disability.
CXCR2 is essential for cerebral endothelial activation and leukocyte recruitment during neuroinflammation.
Does Nrf2 help nerves to survive?
Familial Aggregation of Systemic Lupus Erythematosus and Coaggregation of Autoimmune Diseases in Affected Families.
Expanding the differential diagnosis of inherited neuropathies with non-uniform conduction: Andermann syndrome.
Can we prevent or treat multiple sclerosis by individualised vitamin D supply?
Detection of varicella-zoster virus DNA during medullary and brainstem relapses in multiple sclerosis.
In vivo dentate nucleus MRI relaxometry correlates with previous administration of Gadolinium-based contrast agents.
Functional and structural cerebral changes in key brain regions after a facilitation programme for episodic future thought in relapsing-remitting multiple sclerosis patients.
Gavin Giovannoni on why time matters in multiple sclerosis.
The Neuroprotective Effect of the Association of Aquaporin-4/Glutamate Transporter-1 against Alzheimer's Disease.
Gray Matter Volume Reduction Is Associated with Cognitive Impairment in Neuromyelitis Optica.
Genetic manipulation of microglia during brain development and disease.
Pages
« first
‹ previous
…
688
689
690
691
692
693
694
695
696
…
next ›
last »